AVTX
Avalo Therapeutics Inc
15.00$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +75.8% | -73.4% | +647.5% | +62.9% | -48.6% | +21.2% | +83.3% | -58.4% | -37.1% | +618.0% | -22.7% | |
| – | +77.8% | -73.8% | +94.1% | +99.5% | -19.2% | +46.7% | +137.8% | -73.5% | -48.9% | +1,554.4% | -24.2% | |
| – | +80.2% | -75.8% | -51.8% | +330.6% | -66.1% | +424.2% | +188.5% | -75.9% | -43.7% | +1,714.5% | -88.2% | |
| – | +80.2% | -75.8% | -51.8% | +330.6% | +5.6% | +68.3% | +188.5% | -75.9% | -43.7% | +1,714.5% | -26.9% | |
| – | – | – | +2,115.6% | +107.3% | -13.8% | -16.4% | +9.4% | -60.0% | -92.9% | +349.3% | – | |
| – | – | – | +3,374.1% | +190.7% | -98.1% | -85.9% | +1,166.7% | -47.4% | -100.0% | – | – | |
| – | – | – | – | +1,214.7% | +146.8% | +11.0% | +67.7% | -10.5% | – | – | – | |
| – | – | – | – | +14.8% | -12.2% | 0.0% | +0.0% | +0.0% | -27.1% | +0.0% | +0.0% | |
| – | – | – | – | +76.8% | -92.2% | -34.7% | -97.6% | – | – | – | – | |
| – | -77.8% | -35.1% | +174.4% | +223.3% | -69.4% | +27.0% | +197.7% | -22.5% | -69.1% | +29.3% | +88.8% | |
| – | +17.1% | -26.3% | +164.5% | +129.8% | -53.6% | +25.2% | +30.6% | +11.2% | -79.1% | +50.7% | +85.9% | |
| – | +68.3% | -26.6% | – | – | -85.2% | +173.4% | +13.8% | +1,232.4% | -91.7% | +5.8% | -31.0% | |
| – | -27.2% | +49.0% | +28.6% | +11.3% | +43.7% | +23.9% | +30.9% | -14.5% | -84.5% | -36.5% | -51.6% | |
| – | – | – | – | – | – | – | – | -58.9% | – | – | – | |
| – | – | -98.4% | +13,358.7% | -25.0% | +0.4% | +17.0% | -6.0% | -147.3% | – | +1,721.4% | -37.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.8% | +296.7% | +112.4% | +85.4% | +64.4% | +28.5% | +41.9% | +8.3% | +608.5% | +3,783.0% | +24.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.